CANADA – Eli Health, a Montreal, Canada-based healthcare technology company, raised CAD$5M in funding.
The round was led by Muse Capital, accompanied by RH Capital and Cake Ventures. Other funds such as TELUS Pollinator Fund For Good, Garage Capital, and Leva Capital, also contributed. Longtime supporters, such as Real Ventures, Panache, Vectr, and pan-Canadian consortium MEDTEQ+, reaffirmed their commitment to Eli.The company intends to use the funds to finalize product development and move through clinical validation and regulatory approvals leading to launch.Led by Marina Pavlovic Rivas, CEO, Eli is a women’s health company focused on improving lifelong health by continuously monitoring hormones in saliva. Its at-home technology provides personalized hormone profiles continuously to help how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions.05/04/2023
